SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950142-18-000331
Filing Date
2018-02-07
Accepted
2018-02-07 16:20:09
Documents
1
Group Members
AISLING CAPITAL III, LPAISLING CAPITAL PARTNERS III LLCAISLING CAPITAL PARTNERS III, LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 eh1800134_13ga1-aimmune.htm SC 13G/A 152822
  Complete submission text file 0000950142-18-000331.txt   154596
Mailing Address 888 Seventh Avenue, 30th Fl New York NY 10106
Business Address 888 Seventh Avenue, 30th Fl New York NY 10106 212-651-6380
AISLING CAPITAL III LP (Filed by) CIK: 0001444717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Subject) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88972 | Film No.: 18581371
SIC: 2834 Pharmaceutical Preparations